- Latest available (Revised)
- Original (As made)
This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
61. For the purposes of this Part, a homoeopathic veterinary medicinal product is a veterinary medicinal product (which may contain a number of principles) prepared from substances called homoeopathic stocks in accordance with a homeopathic manufacturing procedure described in the European Pharmacopoeia(1) or, if it is not described there, in a pharmacopoeia published by the British Pharmacopoeial Commission or by the competent authority of any member State.
62.—(1) By way of derogation from the provisions of these Regulations requiring a marketing authorisation, a homoeopathic medicinal product may be placed on the market in accordance with a registration by the Secretary of State instead of a marketing authorisation if it complies with this paragraph.
(2) It must not be an immunological product.
(3) The route of administration must be as described in the European Pharmacopoeia or, if it is not described there, by a pharmacopoeia currently used officially in any member State.
(4) There must be a sufficient degree of dilution to guarantee the safety of the product, and in any event it must not contain more than one part in 10,000 of the mother tincture.
63.—(1) An applicant for registration must submit the following to the Secretary of State—
(a)the scientific name or other name of the homoeopathic stock given in a pharmacopoeia, together with a statement of the various routes of administration, pharmaceutical forms and degree of dilution;
(b)a dossier describing how the homoeopathic stock is obtained and controlled, and justifying its homoeopathic nature, on the basis of an adequate bibliography;
(c)in the case of a product containing biological substances, a description of the measures taken to ensure the absence of pathogens;
(d)the manufacturing and control file for each pharmaceutical form and a description of the method of dilution and potentisation;
(e)a copy of the manufacturing authorisation for the product;
(f)copies of any registrations or authorisations obtained for the same medicinal product in other member States;
(g)a mock-up of the outer packaging and immediate packaging;
(h)stability data;
(i)the proposed withdrawal period necessary to ensure that the provisions of Council Regulation (EEC) No. 2377/90 are complied with together with all necessary justification.
(2) These documents must demonstrate, in particular, the pharmaceutical quality and the batch-to-batch homogeneity of the products concerned.
(3) If a product is registered in another member State, the Secretary of State may waive some or all of the requirements of this paragraph if she is satisfied that it is reasonable to do so.
64.—(1) The procedure for registration is the same as the procedure for granting a marketing authorisation in accordance with Part 3, except—
(a)the applicant is not required to provide proof of therapeutic effect;
(b)the product shall not have a summary of product characteristics;
(c)the Secretary of State shall not publish an assessment report.
(2) The procedure for variation, suspension and revocation is the same as for a marketing authorisation.
65. The requirement to register does not apply in relation to a product that was on the market as a veterinary medicinal product before 1st January 1994.
66. The registration must specify that a homoeopathic veterinary medicinal product may only be administered under the responsibility of a veterinary surgeon.
ISBN 9287145873
The Whole Instrument you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
The Whole Instrument you have selected contains over 200 provisions and might take some time to download.
Would you like to continue?
The Whole Instrument you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
The Schedules you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: